Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs

Monthly topical and sustained-release injectable formulations of moxidectin are currently marketed; however, an oral formulation, while approved at a dose of 3  μg/kg, is not currently marketed in the United St...

Source: Parasites and Vectors - November 9, 2017 Category: Microbiology Authors: Tom L. McTier, Robert H. Six, Aleah Pullins, Sara Chapin, John W. McCall, Douglas Rugg, Steven J. Maeder and Debra J. Woods Tags: Research Source Type: research